Avatar
Drivergrowth

0 Following 0 Followers
1
Task force for the redefinition of myocardial infarction. Universal Definition of Myocardial Infarction. Eur Heart J 2007, 28:2525?538. Budoff MJ, Nasir K, McClelland RL, Detrano R, Wong N, Blumenthal RS, Kondos G, Kronmal RA: Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atheroslcerosis). J Am Coll Cardiol
1
Ociety of cardiology and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J 2012, 33(13):1635?701. Elkeles R, Godsland I, Feher M, Rubens MB, Roughton M, Nugara F, Humphries SE, Richmond W, Flather MD: Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. Eur Heart J 2008, 29:2
1
Of follow-up (months, mean ?sd) CVEV = 1 100 80 87.5 70 16 ?8 44.4 33.3 7.6 ?1.3 171.9 ?291.4 0.4 ?0.2 20 70 80 100 80 60 7.7 ?1.5 39.3 ?46.8 0.7 ?0.4 66.7 55.6 77.8 83.9 66.7 45.7 ?15.6 CVEV = 0 92 70.3 84.1 69.3 13 ?9 21.4 38.6 8.3 ?1.8 45.1 ?122.6 0.4 ?0.4 5.3 46.7 66.7 84 88 49.3 7.6 ?1.6 39.9 ?118.4 0.5 ?0.4 45.8 56.2 79.2 86.3 53.4 45.2 ?13.0 p ns ns ns ns ns ns ns ns ns ns ns ns ns ns ns ns
1
Months (range 18 - 68) was performed. During this period, 10 cardiovascular events (11.8 ) were reported: one unstable angina (1.2 ), seven strokes (8.2 ) and two cardiovascular deaths (2.4 ) ?Table 5. No events were observed in patients with zero CS (0 vs. 19.2 , p = 0.007) or without atherosclerotic plaques (0 vs. 17.5 , p = 0.018), both presenting a negative predictive value of 100 . Seven ev
1
Ause mortality, n ( ) Cardiovascular death Non-cardiovascular death CVEV and CS = 0, n ( ) CVEV and CS
1
Diovascular events (CVEV) in T2DP. Methods: Eighty-five consecutive T2DP undergoing CT (Phillips Brilliance, 16-slice) with CS and CTA were prospectively enrolled in a transversal case-control study. Patients were followed for 48 months (range 18 - 68) to assess CVEV: cardiovascular death, acute coronary syndrome, revascularisation and stroke. Potential predictors of CVEV were identified. Predicti
1
Ulness of CTA or functional tests in screening asymptomatic diabetics [5,7,8,14]. No study to date has demonstrated additional value of CS and CTA when associated to clinical variables and classic risk scores, such as Framingham. This study aims to assess the additional benefit of CS and CTA, when added to clinical risk stratification schemes, to predict fatal and non fatal cardiovascular events i
1
Ce Council: Dutch guidelines for pharmacoeconomic research. Amstelveen: Ziekenfondsraad; 1999.doi:10.1186/1471-2261-14-1 Cite this article as: van Riet et al.: Strategy to recognize and initiate treatment of chronic heart failure in primary care (STRETCH): a cluster randomized trial. BMC Cardiovascular Disorders 2014 14:1.Submit your next manuscript to BioMed Central and take full advantage of:?Co